Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Naseptin nasal cream
1202030S0BBAAAA
|
Naseptin | Neomycin sulfate | Ear, Nose and Oropharynx | 86,293 |
|
Neomycin 0.5% / Chlorhexidine hydrochloride 0.1% cream
1202030S0AAAAAA
|
Neomycin sulfate (Anti-Infective Nasal) | Neomycin sulfate | Ear, Nose and Oropharynx | 47,188 |
|
Neomycin 500mg tablets
0501040N0AAADAD
|
Neomycin sulfate (Systemic) | Neomycin sulfate | Infections | 32 |
|
Neomycin 0.5% cream
1310011P0AAAAAA
|
Neomycin sulfate (Topical) | Neomycin sulfate | Skin | 8 |
|
Cicatrin cream
1310011P0BBAAAG
|
Cicatrin | Neomycin sulfate | Skin | No data available |
|
Cicatrin powder
1310011P0BBABAH
|
Cicatrin | Neomycin sulfate | Skin | No data available |
|
Generic Cicatrin cream
1310011P0AAAGAG
|
Neomycin sulfate (Topical) | Neomycin sulfate | Skin | No data available |
|
Generic Cicatrin powder
1310011P0AAAHAH
|
Neomycin sulfate (Topical) | Neomycin sulfate | Skin | No data available |
|
Generic Neosporin eye drops
1103010N0AAAHAH
|
Neomycin sulfate (Eye) | Neomycin sulfate | Eye | No data available |
|
Graneodin ointment
1310011P0BCAAAJ
|
Graneodin (Topical) | Neomycin sulfate | Skin | No data available |
|
Minims neomycin 0.5% eye drops 0.5ml unit dose
1103010N0BBAAAE
|
Minims neomycin sulfate | Neomycin sulfate | Eye | No data available |
|
Neomycin 0.25% / Gramicidin 0.025% ointment
1310011P0AAAJAJ
|
Neomycin sulfate (Topical) | Neomycin sulfate | Skin | No data available |
|
Neomycin 0.5% eye drops
1103010N0AAAAAA
|
Neomycin sulfate (Eye) | Neomycin sulfate | Eye | No data available |
|
Neomycin 0.5% eye drops 0.5ml unit dose preservative free
1103010N0AAAEAE
|
Neomycin sulfate (Eye) | Neomycin sulfate | Eye | No data available |
|
Neomycin 0.5% eye ointment
1103010N0AAABAB
|
Neomycin sulfate (Eye) | Neomycin sulfate | Eye | No data available |
|
Neomycin 100mg/5ml oral solution
0501040N0AAAJAJ
|
Neomycin sulfate (Systemic) | Neomycin sulfate | Infections | No data available |
|
Neomycin 500mg/5ml oral solution
0501040N0AAAIAI
|
Neomycin sulfate (Systemic) | Neomycin sulfate | Infections | No data available |
|
Neosporin eye drops
1103010N0BFAAAH
|
Neosporin | Neomycin sulfate | Eye | No data available |
|
Nivemycin 500mg tablets
0501040N0BCAAAD
|
Nivemycin (Systemic) | Neomycin sulfate | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.